会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • Control of polymer surface molecular architecture via amphipathic endgroups
    • 通过两亲性端基控制聚合物表面分子结构
    • US20050282997A1
    • 2005-12-22
    • US11211734
    • 2005-08-26
    • Robert WardKeith McCreaYuan TianJames Parakka
    • Robert WardKeith McCreaYuan TianJames Parakka
    • A61L27/14A61L27/18A61L29/06A61L31/06C08F20060101C08F2/00C08G18/08C08G18/12C08G18/28C08G18/50C08G18/62C08G18/67C08G65/00C08G65/329C08G69/08C08J5/00C08L53/00
    • C08G18/6287A61L27/18A61L29/06A61L31/06C08G18/0823C08G18/12C08G18/283C08G18/2865C08G18/289C08G18/5024C08G18/5039C08G18/6283C08G18/6795C08L75/04C08G18/3228
    • Polymers whose surfaces are modified by endgroups that include amphipathic surface-modifying moieties. An amphipathic endgroup of a polymer molecule is an endgroup that contains at least two moieties of significantly differing composition, such that the amphipathic endgroup spontaneously rearranges its positioning in a polymer body to position the moiety on the surface of the body, depending upon the composition of the medium with which the body is in contact, when that re-positioning causes a reduction in interfacial energy. An example of an amphipathic surface-modifying endgroup is one that has both a hydrophobic moiety and a hydrophilic moiety in a single endgroup. For instance, a hydrophilic poly(ethylene oxide) terminated with a hydrophilic hydroxyl group is not surface active in air when the surface-modifying endgroup is bonded to a more hydrophobic base polymer. If the hydroxyl group on the oligomeric poly(ethylene oxide) is replaced by a hydrophobic methoxy ether terminus, the poly(ethylene oxide) becomes surface active in air, and allows the poly(ethylene oxide) groups to crystallize in the air-facing surface. In this example, immersion in water destroys the crystallinity as the poly(ethylene oxide) sorbs water and the hydrophobic methoxy group retreats below the surface of the polymer. Also disclosed are methods and articles of manufacture that make use of these polymers.
    • 其表面被包括两亲表面改性部分的端基修饰的聚合物。 聚合物分子的两亲端基是含有至少两个具有显着不同组成的部分的端基,使得两亲性端基在聚合物体中自发地重排其定位,以将该部分定位在身体的表面上,这取决于 当该重新定位导致界面能量降低时,与身体接触的介质。 两亲性表面改性端基的实例是在单个端基具有疏水部分和亲水部分的实例。 例如,当表面改性端基键合到更疏水的基础聚合物上时,用亲水羟基封端的亲水性聚(环氧乙烷)在空气中不是表面活性的。 如果低聚聚(环氧乙烷)上的羟基被疏水性甲氧基醚末端所代替,则聚(环氧乙烷)在空气中变得表面活性,并允许聚(环氧乙烷)基团在面向空气的表面中结晶 。 在该实施例中,当聚(环氧乙烷)吸附水和疏水性甲氧基在聚合物表面下方退缩时,浸入水中会破坏结晶度。 还公开了利用这些聚合物的方法和制品。
    • 2. 发明申请
    • ANTIMICROBIAL POLYMERS AND THEIR USES
    • 抗微生物聚合物及其用途
    • US20110124772A1
    • 2011-05-26
    • US12994836
    • 2009-05-26
    • Shanger WangRobert S. WardYuan TianLi LiKeith MccreaJames ParakkaRobert L. Jones, JR.
    • Shanger WangRobert S. WardYuan TianLi LiKeith MccreaJames ParakkaRobert L. Jones, JR.
    • C09D175/04C08G71/04
    • A01N33/12A01N47/44A01N25/10A01N2300/00
    • Polymers with non-leaching antimicrobial activity and their use as surface coatings or bulk resins for medical devices. The antimicrobial polymers are prepared with antimicrobial moieties covalently bonded to a polymer chain end or to a polymer backbone at a side chain end. The antimicrobial moiety-containing endgroups include surface active (or surface assembling) moieties which promote enrichment of antimicrobial endgroups at the polymer surface and thus formation of an antimicrobially active surface. Polymers with built-in antimicrobial endgroups can be used as bulk resins, as antimicrobial additives, or as infection preventative coatings in the manufacture of medical devices (e.g., catheters, vascular access devices, peripheral lines, IV sites, drains, gastric feeding and tubes, and other implantable devices). Such materials can also be used as antimicrobial and antifouling coatings on structures in contact with microorganism in environments that require control of biofilm formation, such as marine products.
    • 具有非浸出抗菌活性的聚合物及其用作医疗器械的表面涂层或体积树脂。 抗微生物聚合物通过共价键合到聚合物链末端的抗微生物部分或在侧链末端与聚合物主链一起制备。 含抗微生物部分的端基包括表面活性(或表面组装)部分,其促进抗微生物端基在聚合物表面的富集,从而形成抗微生物活性表面。 具有内置抗微生物端基的聚合物可用作散装树脂,作为抗微生物添加剂,或作为医疗器械制造中的感染预防性涂层(例如,导管,血管通路装置,外围线,IV部位,下水道,胃饲和管 ,和其他可植入装置)。 在需要控制生物膜形成的环境中,例如海产品,这些材料也可用作与微生物接触的结构上的抗微生物和防污涂料。
    • 8. 发明申请
    • SURFACE MODIFICATION OF POLYMERS VIA SURFACE ACTIVE AND REACTIVE END GROUPS
    • 通过表面活性和反应性末端组合聚合物的表面改性
    • US20110293522A1
    • 2011-12-01
    • US13129438
    • 2009-11-16
    • Shanger WangRobert S. WardYuan TianXuwei JiangKeith MccreaScott Curtin
    • Shanger WangRobert S. WardYuan TianXuwei JiangKeith MccreaScott Curtin
    • A61K49/00B29C45/00A61P31/00A61P7/02C08G18/83A61K31/785
    • C08G18/837A61K2800/61C08G18/08C08J7/12C08J7/14
    • Polymer surface modification method comprising the steps of first forming a surface of primary reactive end groups tethered to the polymer chain ends during fabrication of an article, and then modifying the reactive surface with bio-active molecules, hydrophilic and hydrophobic monomers, oligomers, or polymers to attain specific surface properties. Alternatively, a multifunctional coupling agent can be used to couple the primary reactive group to a second reactive group capable of reacting with a functional group associated with bio-active molecules, hydrophilic and hydrophobic monomers, oligomers, and polymers to attain specific surface properties. The invention involves bringing reactive endgroups to the surface with surface active spacer attached to the polymer chain end. The surface active spacer allows the migration and enrichment of reactive end groups to the surface during fabrication. The invention provides medical devices having a bio-interface with anti-thrombogenic properties, lubricity, selective adsorption, and antimicrobial properties.
    • 聚合物表面改性方法包括以下步骤:在制品制造期间首先形成与聚合物链末端连接的主要反应性端基的表面,然后用生物活性分子,亲水和疏水单体,低聚物或聚合物改性活性表面 以获得特定的表面性质。 或者,多功能偶联剂可用于将主反应性基团与能够与与生物活性分子,亲水和疏水单体,低聚物和聚合物相关的官能团反应的第二反应性基团,以获得特定的表面性质。 本发明涉及将表面活性隔离物连接到聚合物链末端的反应性端基引入表面。 表面活性间隔物允许反应性端基在制造过程中迁移和富集到表面。 本发明提供具有抗血栓形成性质,润滑性,选择性吸附和抗微生物性质的生物界面的医疗装置。